WO2019013613A3 - Métodos y kits para determinar el riesgo de cáncer - Google Patents

Métodos y kits para determinar el riesgo de cáncer Download PDF

Info

Publication number
WO2019013613A3
WO2019013613A3 PCT/MX2018/000084 MX2018000084W WO2019013613A3 WO 2019013613 A3 WO2019013613 A3 WO 2019013613A3 MX 2018000084 W MX2018000084 W MX 2018000084W WO 2019013613 A3 WO2019013613 A3 WO 2019013613A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
methods
determining
kids
risk
Prior art date
Application number
PCT/MX2018/000084
Other languages
English (en)
French (fr)
Other versions
WO2019013613A2 (es
Inventor
Martha Gisela AGUIRRE GIL
Elizabeth MEDA MONZÓN
Lucero DELGADO PASTELIN
Original Assignee
Hakken Enterprise Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL1042665A external-priority patent/NL1042665B1/en
Priority claimed from MX2018008471A external-priority patent/MX2018008471A/es
Application filed by Hakken Enterprise Sa De Cv filed Critical Hakken Enterprise Sa De Cv
Priority to EP18832907.2A priority Critical patent/EP3854886A4/en
Publication of WO2019013613A2 publication Critical patent/WO2019013613A2/es
Publication of WO2019013613A3 publication Critical patent/WO2019013613A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se divulgan métodos y equipos para determinar la susceptibilidad del cáncer o diagnosticar un cáncer en un sujeto al realizar una identificación y detección simultáneas de genotipos de cepas del VPH y marcadores genéticos para la susceptibilidad al cáncer en una muestra de un sujeto.
PCT/MX2018/000084 2017-07-09 2018-09-03 Métodos y kits para determinar el riesgo de cáncer WO2019013613A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP18832907.2A EP3854886A4 (en) 2017-11-30 2018-09-03 METHODS AND KITS FOR DETERMINING CANCER RISK

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762530245P 2017-07-09 2017-07-09
US62/530,245 2017-07-09
NL1042665 2017-11-30
NL1042665A NL1042665B1 (en) 2017-11-30 2017-11-30 Methods and kits for determining risk of cancer
MX2018008471A MX2018008471A (es) 2017-07-09 2018-07-09 Metodos y kits para determinar el riesgo de cancer.
MXMX/A/2018/008471 2018-07-09

Publications (2)

Publication Number Publication Date
WO2019013613A2 WO2019013613A2 (es) 2019-01-17
WO2019013613A3 true WO2019013613A3 (es) 2019-12-19

Family

ID=65002178

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2018/000084 WO2019013613A2 (es) 2017-07-09 2018-09-03 Métodos y kits para determinar el riesgo de cáncer

Country Status (1)

Country Link
WO (1) WO2019013613A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3187549A1 (en) 2020-07-30 2022-02-03 Cambridge Epigenetix Limited Compositions and methods for nucleic acid analysis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100047806A1 (en) * 2007-10-09 2010-02-25 Arkray, Inc. Probes for detecting immune-related gene polymorphisms and applications of the same
WO2010102160A2 (en) * 2009-03-05 2010-09-10 The Johns Hopkins University Diagnostic method using palb2
EP2915883A1 (en) * 2014-03-07 2015-09-09 Ruprecht-Karls-Universität Heidelberg Non-invasive assay for early detection of cancer
US20170166982A1 (en) * 2010-09-03 2017-06-15 Centre National De La Recherche Scientifique (Cnrs) Analytical methods for cell free nucleic acids and applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003268333A1 (en) 2003-02-28 2004-09-28 Ravgen, Inc. Methods for detection of genetic disorders
WO2007109854A1 (en) 2006-03-28 2007-10-04 Diatech Pty Ltd A method of genotyping cells using real-time pcr
WO2009095840A1 (en) 2008-01-31 2009-08-06 Koninklijke Philips Electronics N. V. Method for simultaneous detection of pathogens and genetic profiling of the host using a single array
US20110212855A1 (en) 2008-08-15 2011-09-01 Decode Genetics Ehf. Genetic Variants Predictive of Cancer Risk
EP2358915B1 (en) 2008-10-31 2016-08-10 TrovaGene, Inc. A genetic marker for detection of human papillomavirus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100047806A1 (en) * 2007-10-09 2010-02-25 Arkray, Inc. Probes for detecting immune-related gene polymorphisms and applications of the same
WO2010102160A2 (en) * 2009-03-05 2010-09-10 The Johns Hopkins University Diagnostic method using palb2
US20170166982A1 (en) * 2010-09-03 2017-06-15 Centre National De La Recherche Scientifique (Cnrs) Analytical methods for cell free nucleic acids and applications
EP2915883A1 (en) * 2014-03-07 2015-09-09 Ruprecht-Karls-Universität Heidelberg Non-invasive assay for early detection of cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HERRERO , R ET AL.: "Human Papillomavirus (HPV) Vaccines: Limited Cross-Protection against Additional HPV Types", THE JOURNAL OF INFECTIOUS DISEASES, vol. 199, no. 7, 1 April 2009 (2009-04-01), pages 919 - 922, XP055665890 *
MERSCH, J ET AL.: "Cancers Associated with BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian", CANCER, vol. 121, no. 2, 15 January 2015 (2015-01-15), pages 269 - 275, XP055665896 *
NUNOBIKI, O ET AL.: "Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis", PATHOLOGY RESEARCH INTERNATIONAL, vol. 2011, no. 364069, 31 May 2011 (2011-05-31), pages 1 - 8, XP055665888 *

Also Published As

Publication number Publication date
WO2019013613A2 (es) 2019-01-17

Similar Documents

Publication Publication Date Title
WO2015114506A3 (en) Biosensors for the detection of infection and associated maladies
WO2015058008A3 (en) Enhanced nucleic acid identification and detection
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
PL3482209T3 (pl) Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii
EP3405559A4 (en) FAST ANTIBIOGRAM CARRIED OUT BY HIGH-SENSITIVITY DIRECT DETECTION METHODS
USD740434S1 (en) Laboratory apparatus
WO2015187018A3 (en) Means and methods for determining t cell recognition
EP3980558A4 (en) METHODS AND REAGENTS FOR THE AMPLIFICATION AND/OR DETECTION OF NUCLEIC ACIDS
WO2015153948A3 (en) Microtentacle imaging in patient tumor samples
EP3690063A3 (en) Diagnosis of lung cancer
IL254687B1 (en) A bio-sensor system for rapid identification of an analyte
EP3299816A4 (en) Separation method, detection method, signal measurement method, disease determination method, drug efficacy assessment method, kit, liquid composition, and specimen diluent
WO2016205637A3 (en) Detection of cerebrospinal fluid
MX371098B (es) Deteccion de malaria.
EP3385717A3 (en) Methods of detecting prostate cancer
WO2016172179A3 (en) Metagenomic compositions and methods for the detection of breast cancer
EP3693742A3 (en) Methods of detecting prostate cancer
EP3561729A4 (en) DETECTION AND RECOGNITION OF WIDE RANGE AND HIGH DENSITY VISUAL MARKERS
WO2016205828A3 (en) Role of citrullination in diagnosing diseases
WO2016014240A3 (en) Compositions and methods for the detection and analysis of mycobacterium tuberculosis
WO2015166353A3 (en) Early detection of preeclampsia
WO2015176006A3 (en) Genetic detection platform
WO2017181163A3 (en) Methods and compositions for detection and diagnosis of breast cancer
WO2019013613A3 (es) Métodos y kits para determinar el riesgo de cáncer

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18832907

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 18832907

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 18-06-2020)

ENP Entry into the national phase

Ref document number: 2018832907

Country of ref document: EP

Effective date: 20200210